|
WO2020219620A1
|
|
Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
|
|
WO2020219619A1
|
|
Systems and methods for interactive adjustment of intensity windowing in nuclear medicine images
|
|
US2021093249A1
|
|
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
WO2020077270A1
|
|
Methods of making prostate cancer treatment decisions
|
|
WO2020077259A1
|
|
Combination therapy for treating metastatic prostate cancer
|
|
CN111602174A
|
|
System and method for rapidly segmenting images and determining radiopharmaceutical uptake based on neural network
|
|
US2020342600A1
|
|
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
US2019209116A1
|
|
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
AU2017348111A1
|
|
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
|
|
AU2014201056A1
|
|
Crystal forms of (r) -n-methylnaltrexone bromide and uses thereof
|
|
AU2014200916A1
|
|
Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
|
|
AU2013203378A1
|
|
Pharmaceutical formulations containing methylnaltrexone
|
|
AU2013200437A1
|
|
(S)-N-methylnaltrexone, process for its synthesis and its pharmaceutical use
|
|
AU2012211459A1
|
|
(R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use
|
|
AU2011239470A1
|
|
Antibodies for the treatment of Clostridium difficile-associated infection and disease
|
|
EP2303890A2
|
|
Phosphatidylinositol 3 kinase inhibitors
|
|
WO2009134401A2
|
|
Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1
|
|
EP2231624A2
|
|
Triazines and related compounds having antiviral activity, compositions and methods thereof
|
|
WO2009067275A1
|
|
N-oxides of 4,5-epoxy-morphinanium analogs
|
|
WO2008134076A1
|
|
Methods for reducing viral load in hiv-1-infected patients
|
